Truvestments Capital’s Boston Scientific BSX Stock Holding History

Truvestments Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$79.2K	Hold	1,263	–	–	0.01%	428
2025 Q4	$120K	Sell	1,263 -302	-19%	-$29.6K	0.02%	314
2025 Q3	$153K	Buy	1,565 +217	+16%	+$22.5K	0.03%	302
2025 Q2	$145K	Sell	1,348 -174	-11%	-$17.6K	0.03%	260
2025 Q1	$154K	Buy	1,522 +942	+162%	+$94.9K	0.03%	257
2024 Q4	$51.8K	Hold	580	–	–	0.01%	364
2024 Q3	$48.6K	Buy	+580	New	+$45.7K	0.01%	362
2021 Q2	–	Sell	-1,694	Closed	-$65K	–	631
2021 Q1	$65K	Sell	1,694 -51	-3%	-$1.93K	0.04%	256
2020 Q4	$63K	Buy	1,745 +751	+76%	+$27.1K	0.04%	231
2020 Q3	$38K	Sell	994 -48	-5%	-$1.85K	0.03%	195
2020 Q2	$35K	Buy	1,042 +344	+49%	+$12.4K	0.04%	244
2020 Q1	$22K	Buy	+698	New	+$27.3K	0.03%	253
2019 Q4	–	Sell	-1,998	Closed	-$81K	–	206
2019 Q3	$81K	Hold	1,998	–	–	0.05%	192
2019 Q2	$86K	Hold	1,998	–	–	0.06%	198
2019 Q1	$77K	Buy	+1,998	New	+$76.3K	0.06%	185
2018 Q3	$77K	Buy	+1,998	New	+$69.8K	0.04%	298

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Truvestments Capital's BSX Position: Q1 2026 in Review

Truvestments Capital held its Boston Scientific (BSX) position steady in Q1 2026 at 1,263 shares worth $79.2K. The position accounts for 0.01% of the portfolio, ranked #428.

Truvestments Capital first reported a position in BSX in Q3 2018 and has held it in 16 quarters since. The position peaked at $154K in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Truvestments Capital held 1,263 shares of Boston Scientific worth $79.2K as of Q1 2026.
Truvestments Capital left its Boston Scientific share count unchanged in Q1 2026.
Boston Scientific made up 0.01% of Truvestments Capital's portfolio in Q1 2026, its #428 holding.
Truvestments Capital first reported a position in Boston Scientific in Q3 2018 and has held it in 16 quarters since.
Truvestments Capital's Boston Scientific position peaked at $154K in Q1 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.